Disclosure of Conflict of Interest at the Annual Meetings of the Japanese Cancer Association
In cancer studies derived from industry-academic collaboration, there are not only benefits to society from the outcomes of research (public interest) but also money, status, rights and other benefits (private interest) that may be entailed. If these two types of benefits coincide with an individual researcher, it is called conflict of interest.
The Japanese Cancer Association (JCA) asks speakers at the annual meetings of the JCA to disclose their status of Conflict of Interest (COI) to ensure the fairness of presentations of studies at the meetings, according to ‘JCA Detailed Regulations on the Handling of Conflict of Interest’, which started from 2009 and was revised in April 2011.
Since the 2011 annual meeting, the Japanese Cancer Association has received self-reports on conflict of interest not only in clinical research but in all research including basic research.
When the lead presenters submit an abstract, please check whether or not there are conflicts of interest with a company or for-profit group related to the subject of the presentation. If there is a COI, you should disclose your status of COI within the past 3 years on the COI Disclosure Form. (Co-presenters do not need to make a disclosure.)
Please note that the declaration of COI status is required when you submit your abstract to the The 71st Annual Meeting of the Japanese Cancer Association.
For more details, please access the abstract registration website and check whether or not there is a COI related to your presentation. You should also disclose your status of COI during your presentation at the annual meeting (either slide or poster presentations).
Please refer to the following Detailed Regulations for more information.